Novavax announce promising RSV vaccine Phase II results

Novavax have reported positive results of a Phase II clinical trial of its respiratory syncytial virus (RSV) vaccine candidate as a maternal immunization strategy. Novavax say that the randomized, blinded, placebo-controlled, dose-ranging Phase II clinical trial of the RSV F protein nanoparticle vaccine candidate accomplished the trial's protocol-specified objectives and supports progression to the next stage. Maternal immunization is a …

Why when vaccine trials fail it is a sad day for global public health

It saddens me to read about failed clinical trials in vaccines for many reasons, but mostly because of the impact these failures might have on the wider global vaccine research and development. With the recent news about Sanofi Pasteur's not as effective phase II trial results for their Dengue Fever vaccine, it just made me think how this will affect …